Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

EMA Drops Requirement for Testing Untreated Hemophilia Patients in Draft Guidelines

  • Post author:Sam
  • Post published:October 30, 2017
  • Post category:Drug Industry Daily

The European Medicines Agency revised two guidelines on the development and labeling of factor VIII products used to treat hemophilia A, removing requirements for sponsors to conduct clinical trials in…

Continue ReadingEMA Drops Requirement for Testing Untreated Hemophilia Patients in Draft Guidelines

EMA Issues New Guideline on RSV Products

  • Post author:Sam
  • Post published:October 30, 2017
  • Post category:Drug Industry Daily

The European Medicines Agency published a new draft guideline on developing medicines and vaccines against respiratory syncytial virus infections, including monoclonal antibodies and direct-acting antivirals. Source: Drug Industry Daily

Continue ReadingEMA Issues New Guideline on RSV Products

FDA to Adopt ICH E9 Addendum on Clinical Trials Analyses

  • Post author:Sam
  • Post published:October 30, 2017
  • Post category:Drug Industry Daily

The FDA is seeking public comments on an ICH addendum to a 1998 clinical trials statistics guideline focused on the use of sensitivity analyses and targets for estimation and measurement.…

Continue ReadingFDA to Adopt ICH E9 Addendum on Clinical Trials Analyses

FDA to Consider New Requirements for Opioid Packaging to Limit Exposure

  • Post author:Sam
  • Post published:October 30, 2017
  • Post category:Drug Industry Daily

The FDA is looking for creative approaches to the opioid crisis, including new requirements for product packaging, as ways to reduce overall exposure to the painkillers. Source: Drug Industry Daily

Continue ReadingFDA to Consider New Requirements for Opioid Packaging to Limit Exposure

Kymera Emerges Out of Stealth Mode With $30M and a Top Team of Drug Hunters

  • Post author:Sam
  • Post published:October 29, 2017
  • Post category:BioPharma

Kymera Therapeutics launched with a $30M Series A financing which was lead by Atlas Venture. Source: BioSpace

Continue ReadingKymera Emerges Out of Stealth Mode With $30M and a Top Team of Drug Hunters

Shire in Talks to Sell 100-Employee Facility in Massachusetts

  • Post author:Sam
  • Post published:October 29, 2017
  • Post category:BioPharma

As part of consolidation program, Shire is looking to sell a manufacturing facility in Milford, MA that it gained through its 2015 acquisition of Baxalta. Source: BioSpace

Continue ReadingShire in Talks to Sell 100-Employee Facility in Massachusetts

This is the Fastest-Growing Private Pharma in the Bay Area

  • Post author:Sam
  • Post published:October 29, 2017
  • Post category:BioPharma

Want to work for a company having a growth spurt? Source: BioSpace

Continue ReadingThis is the Fastest-Growing Private Pharma in the Bay Area

Insys Sales Execs Allegedly Made a Rap Video of Themselves Dancing With Their Deadly Fentanyl Spray

  • Post author:Sam
  • Post published:October 29, 2017
  • Post category:BioPharma

Insys continues to receive an optics beating in the wake of the charges against company founder John Kapoor and multiple executives surrounding illegal sales practices of its cancer pain drug.…

Continue ReadingInsys Sales Execs Allegedly Made a Rap Video of Themselves Dancing With Their Deadly Fentanyl Spray

The Complicated Relationship Between Celgene and President Trump

  • Post author:Sam
  • Post published:October 29, 2017
  • Post category:BioPharma

On multiple occasions, President Donald Trump has aimed his ire at pharma companies. Source: BioSpace

Continue ReadingThe Complicated Relationship Between Celgene and President Trump

Fosun Pharma to Buy France's Tridem for $73M

  • Post author:Sam
  • Post published:October 29, 2017
  • Post category:BioPharma

Fosun Pharma said it would buy Tridem Pharma S.A.S. for $73M, in a move to expand its market share in Europe and Africa. Source: BioSpace

Continue ReadingFosun Pharma to Buy France's Tridem for $73M
  • Go to the previous page
  • 1
  • …
  • 274
  • 275
  • 276
  • 277
  • 278
  • 279
  • 280
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.